Clinical Trials Logo

Clinical Trial Summary

Prospective longitudinal study of adult patients with moderate to severe chronic hand eczema to characterize the disease and evaluate its association with quality of life.


Clinical Trial Description

Prospective longitudinal study of adult patients with moderate to severe chronic hand eczema to characterize the pathophysiology of chronic hand eczema and assess changes in morphological parameters and molecular signatures with non-invasive techniques. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05026554
Study type Observational
Source Innovaderm Research Inc.
Contact Ana Palijan, PhD
Phone 5145214285
Email [email protected]
Status Recruiting
Phase
Start date June 30, 2021
Completion date December 2023

See also
  Status Clinical Trial Phase
Completed NCT03683719 - Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema Phase 2
Recruiting NCT04872101 - Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) Phase 3
Completed NCT01482663 - Chronic Hand Eczema - Self-management and Prognosis N/A
Recruiting NCT04871711 - Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema Phase 3
Recruiting NCT03861455 - Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids Phase 2
Enrolling by invitation NCT04949841 - Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials Phase 3
Completed NCT03246776 - Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan Phase 4
Completed NCT04378569 - Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema Phase 1/Phase 2